Evidence map›Paper›PMID 35454908›Full record

ReviewCancers2022

Bioelectrical Phase Angle in Patients with Breast Cancer: A Systematic Review.

Delia Morlino, Iolanda Cioffi, Maurizio Marra, Olivia Di Vincenzo, Luca Scalfi, Fabrizio Pasanisi

Abstract readReview
In one paragraph

Review in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Observational
  2. The prognostic impact of perioperative metabolic variables in head and neck cancer: a prospective study.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2026
    Observational
  3. Novel insights into phase angle in breast cancer - stage-specific associations between body composition and metabolic age.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2026
    Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Future lines of research on phase angle: Strengths and limitations.Reviews in endocrine & metabolic disorders · 2023
    Review
  14. The role of bioelectrical phase angle in patients with heart failure.Reviews in endocrine & metabolic disorders · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Delia MorlinoDepartment of Clinical Medicine and Surgery, Federico II University Hospital, Pansini 5, 80131 Naples, Italy.ORCID 0000-0002-3158-450X
Iolanda CioffiDepartment of Clinical Medicine and Surgery, Federico II University Hospital, Pansini 5, 80131 Naples, Italy.ORCID 0000-0002-1408-209X
Maurizio MarraDepartment of Clinical Medicine and Surgery, Federico II University Hospital, Pansini 5, 80131 Naples, Italy.ORCID 0000-0002-3258-7374
Olivia Di VincenzoDepartment of Public Health, Federico II University Hospital, Pansini 5, 80131 Naples, Italy.ORCID 0000-0003-3152-3130
Luca ScalfiDepartment of Public Health, Federico II University Hospital, Pansini 5, 80131 Naples, Italy.
Fabrizio PasanisiDepartment of Clinical Medicine and Surgery, Federico II University Hospital, Pansini 5, 80131 Naples, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer (BC) is the most common cancer diagnosed among women worldwide. Phase angle (PhA), a proxy measure of membrane integrity and function, has gained relevance in clinical practice and it has been suggested to be a prognostic and nutritional indicator. This systematic review aimed to explore PhA and its relationship with nutritional status and survival in BC patients. Four databases (PubMed, EMBASE, Web of Science, and CINAHL) were systematically searched until September 2021 for studies evaluating PhA in BC patients. A total of 16 studies met the inclusion criteria, where 11 were observational studies and 5 were interventional studies. Baseline PhA-value varied from 4.9 to 6.30 degrees, showing a great variability and heterogeneity across the selected studies. Available data suggested that PhA decreased by 5-15% after completing chemotherapy, and those effects might persist in the long term. However, the use of tailored nutritional and/or exercise programs during and after therapy could prevent PhA reduction and body derangement. High PhA values were found in women displaying a better nutritional status, while inconsistent data were found on survival. Therefore, further studies are needed to focus on the clinical relevance of PhA in BC patients, evaluating its association with disease outcomes and survival.

Indexed as

bioimpedance-analysischemotherapyfat massmuscle strengthsurvival

Identifiers

PMID35454908
PMCPMC9025027

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.